
Molecules, Journal Year: 2024, Volume and Issue: 29(22), P. 5481 - 5481
Published: Nov. 20, 2024
Acetylcholinesterase and butyrylcholinesterase are two related enzymes that represent pharmacologically suitable targets in neurodegenerative disorders, given their physiological roles the body. The treatment of disorders currently includes common reversible cholinesterase inhibitors. Resveratrol analogues, as molecules focus, have shown very strong inhibition potential cholinesterases. In this research, experimental DFT approaches for p
Language: Английский